/Gilead%20Sciences%2C%20Inc_%20Meeting%20Center-by%20Sundry%20Photography%20via%20iStock.jpg)
Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, with a market cap of $115.3 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in antiviral therapies, oncology, and other critical therapeutic areas, Gilead is dedicated to advancing health outcomes, driving medical breakthroughs, and addressing unmet medical needs worldwide.
Companies valued at over $10 billion are typically classified as “large-cap stocks,” a category that Gilead Sciences exemplifies through its remarkable scale, innovation, and industry leadership.